Definium Therapeutics Stock Alpha and Beta Analysis
| DFTX Stock | 16.90 0.65 4.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Definium Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Definium Therapeutics over a specified time horizon. Remember, high Definium Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Definium Therapeutics' market risk premium analysis include:
Beta 1.45 | Alpha 0.16 | Risk 3.88 | Sharpe Ratio 0.17 | Expected Return 0.67 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Definium Therapeutics Analysis, Definium Therapeutics Valuation, Definium Therapeutics Correlation, Definium Therapeutics Hype Analysis, Definium Therapeutics Volatility, Definium Therapeutics Price History and analyze Definium Therapeutics Performance. Definium Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Definium Therapeutics market risk premium is the additional return an investor will receive from holding Definium Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Definium Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Definium Therapeutics' performance over market.| α | 0.16 | β | 1.45 |
Definium Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Definium Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Definium Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Definium Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Definium Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Definium Therapeutics shares will generate the highest return on investment. By understating and applying Definium Therapeutics stock market price indicators, traders can identify Definium Therapeutics position entry and exit signals to maximize returns.
Definium Therapeutics Return and Market Media
The median price of Definium Therapeutics for the period between Sun, Nov 9, 2025 and Sat, Feb 7, 2026 is 12.95 with a coefficient of variation of 15.18. The daily time series for the period is distributed with a sample standard deviation of 2.06, arithmetic mean of 13.57, and mean deviation of 1.69. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Assessing Mind Medicine Valuation After Rebrand To Deinium Therapeutics And Pipeline Progress | 01/16/2026 |
2 | Deinium Therapeutics Is Up 11.5 percent After Psychedelic Rebrand And DT120 Roadmap Reveal Has The Bull Case Changed - simplywall.st | 01/21/2026 |
3 | Definium Therapeutics Announces New Employee Inducement Grants - Business Wire | 01/26/2026 |
4 | Is Adsetts Board Appointment And Breakthrough DT120 Status Altering The Investment Case For Definium Therapeutics | 02/05/2026 |
About Definium Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Definium or other stocks. Alpha measures the amount that position in Definium Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2025 | 2026 (projected) | Net Current Asset Value | 178.9K | 171.4K | 147.7K | Days Payables Outstanding | 477.43 | 1.3K | 747.82 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Definium Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Definium Therapeutics' short interest history, or implied volatility extrapolated from Definium Therapeutics options trading.
Build Portfolio with Definium Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Definium Stock Analysis
When running Definium Therapeutics' price analysis, check to measure Definium Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definium Therapeutics is operating at the current time. Most of Definium Therapeutics' value examination focuses on studying past and present price action to predict the probability of Definium Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definium Therapeutics' price. Additionally, you may evaluate how the addition of Definium Therapeutics to your portfolios can decrease your overall portfolio volatility.